Skip to main content
Top
Published in: Obesity Surgery 4/2009

01-04-2009 | Research Article

Vagal Nerve Dissection During Pouch Formation in Laparoscopic Roux-Y-Gastric Bypass for Technical Simplification: Does it Matter?

Authors: A. Perathoner, H. Weiss, W. Santner, G. Brandacher, E. Laimer, E. Höller, F. Aigner, A. Klaus

Published in: Obesity Surgery | Issue 4/2009

Login to get access

Abstract

Background

In Roux-Y gastric bypass surgery pouch formation is the most demanding part of the operation. The vagal nerve is usually tempted to be preserved although results reporting beneficial effects are lacking. Dividing the perigastric tissue including the anterior vagal trunk may technically alleviate gastric pouch formation. We evaluated the clinical outcome in patients with and without vagal nerve dissection in patients after Roux-Y gastric bypass (RY-BP).

Methods

In this study 40 morbidly obese patients undergoing RY-BP have been included. Patients were divided into two groups according to vagal nerve preservation (Group 1, n = 25) or vagal nerve dissection (Group 2, n = 22). Clinical parameters (weight loss, complications, gastrointestinal symptoms), esophageal endoscopy, and motility data (manometry, pH-metry) and a satiety score were assessed. Serum values of ghrelin and gastrin were measured.

Results

All procedures were performed by laparoscopy with a 0% mortality rate. One patient of each groups necessitated redo-laparoscopy (bleeding and a lost drainage). All patients significantly reduced body weight (p < 0.01 compared to preoperative) during a median follow-up of 36.1 months. Two patients of Group 2 showed acid reflux demonstrated by pathologic postoperative DeMeester scores. Esophageal body peristalsis and barium swallows did not reveal statistically significant differences between the two groups. Parameters of satiety assessment did not differ between the two groups as did serum values of gastrin and ghrelin.

Conclusion

Pouch formation during RY-BP may be alleviated by simply dissecting the perigastric fatty tissue. In this way the anterior vagal trunk is dissected, however, no influence on clinical, functional and laboratory results occur.
Literature
1.
go back to reference Suter M, Paroz A, Calmes JM, et al. European experience with laparoscopic Roux-en-Y bypass in 466 obese patients. Br J Surg 2006;93(6):726–32. Jun.CrossRef Suter M, Paroz A, Calmes JM, et al. European experience with laparoscopic Roux-en-Y bypass in 466 obese patients. Br J Surg 2006;93(6):726–32. Jun.CrossRef
2.
go back to reference Müller MK, Guber J, Wildi S, et al. Three-year-follow-up study of retrocolic versus antecolic laparoscopic Roux-en-Y gastric bypass. Obes Surg 2007;17(7):889–93. Jul.CrossRef Müller MK, Guber J, Wildi S, et al. Three-year-follow-up study of retrocolic versus antecolic laparoscopic Roux-en-Y gastric bypass. Obes Surg 2007;17(7):889–93. Jul.CrossRef
3.
go back to reference le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246:780–5. Nov.CrossRef le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246:780–5. Nov.CrossRef
4.
go back to reference Weiner S, Sauerland S, Fein M, et al. The bariatric quality of life index: a measure of well-being in obesity surgery patients. Obes Surg 2005;15(4):538–45. Apr.CrossRef Weiner S, Sauerland S, Fein M, et al. The bariatric quality of life index: a measure of well-being in obesity surgery patients. Obes Surg 2005;15(4):538–45. Apr.CrossRef
5.
go back to reference Adams T. Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753–61. Aug 23.CrossRef Adams T. Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753–61. Aug 23.CrossRef
6.
go back to reference Lee H, Te C, Koshy S, et al. Does Ghrelin really matter after bariatric surgery? Surg Obes Relat Dis 2006;2:538–48.CrossRef Lee H, Te C, Koshy S, et al. Does Ghrelin really matter after bariatric surgery? Surg Obes Relat Dis 2006;2:538–48.CrossRef
7.
go back to reference Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001;120:337–45.CrossRef Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001;120:337–45.CrossRef
8.
go back to reference Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-indiced feeding and growth hormone secretion in rats. Gastroenterology 2002;123:1120–8.CrossRef Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-indiced feeding and growth hormone secretion in rats. Gastroenterology 2002;123:1120–8.CrossRef
9.
go back to reference Frühbeck G, Rotellar F, Hernandez-Lizoain JL, et al. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg 2004;14:1208–15.CrossRef Frühbeck G, Rotellar F, Hernandez-Lizoain JL, et al. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg 2004;14:1208–15.CrossRef
10.
go back to reference Maier C, Schaller G, Buranyi B, et al. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab 2004;89:4729–33.CrossRef Maier C, Schaller G, Buranyi B, et al. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab 2004;89:4729–33.CrossRef
11.
go back to reference Arosio M, Ronchi CL, Beck-Peccoz P, et al. Effects of modified sham feeding on ghrelin levels in healthy human subjects. J Clin Endocrinol Metab 2004;89:5101–4.CrossRef Arosio M, Ronchi CL, Beck-Peccoz P, et al. Effects of modified sham feeding on ghrelin levels in healthy human subjects. J Clin Endocrinol Metab 2004;89:5101–4.CrossRef
12.
go back to reference Simonian HP, Kresge KM, Boden GH, et al. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol Motil 2005;17:348–54.CrossRef Simonian HP, Kresge KM, Boden GH, et al. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol Motil 2005;17:348–54.CrossRef
13.
go back to reference Pudel D, Westenhöfer J. Fragebogen zum Essverhalten (FEV). Handanweisung, Göttingen: Hogrefep. 1989. Pudel D, Westenhöfer J. Fragebogen zum Essverhalten (FEV). Handanweisung, Göttingen: Hogrefep. 1989.
14.
go back to reference Weiss HG, Nehoda H, Labeck B, et al. Treatment of morbid obesity with laparoscopic adjustable gastric banding affects esophageal motility. Am J Surg 2000;180(6):479–82. Dec.CrossRef Weiss HG, Nehoda H, Labeck B, et al. Treatment of morbid obesity with laparoscopic adjustable gastric banding affects esophageal motility. Am J Surg 2000;180(6):479–82. Dec.CrossRef
15.
go back to reference Hinder RA, Filipi CJ, Wetscher G, et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994;220:472–83.CrossRef Hinder RA, Filipi CJ, Wetscher G, et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994;220:472–83.CrossRef
16.
go back to reference Wetscher GJ, Gadenstaetter M, Klingler PJ, et al. Efficacy of medical therapy and antireflux surgery to prevent Barrett’s metaplasia in patients with gastroesophageal reflux disease. Ann Surg 2001;234:627–32.CrossRef Wetscher GJ, Gadenstaetter M, Klingler PJ, et al. Efficacy of medical therapy and antireflux surgery to prevent Barrett’s metaplasia in patients with gastroesophageal reflux disease. Ann Surg 2001;234:627–32.CrossRef
17.
go back to reference DeMeester TR, Wang CI, Wernly JA, et al. Technique, indications and clinical use of 24-hour esophageal pH monitoring. J Thorac Cardiovasc Surg 1980;79:656–70.PubMed DeMeester TR, Wang CI, Wernly JA, et al. Technique, indications and clinical use of 24-hour esophageal pH monitoring. J Thorac Cardiovasc Surg 1980;79:656–70.PubMed
18.
go back to reference Livingston EH, Elliott AC, Hynan LS, et al. When policy meets statistics: the very real effect that questionable statistical analysis has on limiting health care access for bariatric surgery. Arch Surg 2007;142:979–87.CrossRef Livingston EH, Elliott AC, Hynan LS, et al. When policy meets statistics: the very real effect that questionable statistical analysis has on limiting health care access for bariatric surgery. Arch Surg 2007;142:979–87.CrossRef
19.
go back to reference Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007;142:621–32.CrossRef Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007;142:621–32.CrossRef
20.
go back to reference Murr MM, Martin T, Torrella T, et al. A state-wide review of contemporary outcomes of gastric bypass in Florida: does provider volume impact outcomes? Ann Surg 2007;245:699–706.CrossRef Murr MM, Martin T, Torrella T, et al. A state-wide review of contemporary outcomes of gastric bypass in Florida: does provider volume impact outcomes? Ann Surg 2007;245:699–706.CrossRef
21.
go back to reference Flum DR, Dellinger EP. Impact of gastric bypass operations on survival: a population based analysis. J Am Coll Surg 2004;199:543–51.CrossRef Flum DR, Dellinger EP. Impact of gastric bypass operations on survival: a population based analysis. J Am Coll Surg 2004;199:543–51.CrossRef
22.
go back to reference Latarjet A. Section des rameaux gastrique du vague. La Presse Med 1921;41:409. Latarjet A. Section des rameaux gastrique du vague. La Presse Med 1921;41:409.
23.
go back to reference McCrea ED. The abdominal distribution of the vagus. J Anat (London) 1924;59:18–40. McCrea ED. The abdominal distribution of the vagus. J Anat (London) 1924;59:18–40.
24.
go back to reference Ando S, Tsuji H. Surgical technique of vagus nerve-preserving gastrectomy with D2 lymphadenectomy for gastric cancer. ANZ J Surg 2008;78:172–6.CrossRef Ando S, Tsuji H. Surgical technique of vagus nerve-preserving gastrectomy with D2 lymphadenectomy for gastric cancer. ANZ J Surg 2008;78:172–6.CrossRef
25.
go back to reference Skandalakis LJ, Donahue PE, Skandalakis JE. The vagus nerve and its vagaries. Surg Clin North Α 1993;73:769–84.CrossRef Skandalakis LJ, Donahue PE, Skandalakis JE. The vagus nerve and its vagaries. Surg Clin North Α 1993;73:769–84.CrossRef
26.
go back to reference Moran TH, Kinzig KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004;286:G183–8.CrossRef Moran TH, Kinzig KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004;286:G183–8.CrossRef
27.
go back to reference Smith GP. The direct and indirect controls of meal size. Neurosci Biobehav Rev 1996;20:41–6.CrossRef Smith GP. The direct and indirect controls of meal size. Neurosci Biobehav Rev 1996;20:41–6.CrossRef
28.
go back to reference Powel TL, Chi MM, Schier LA, et al. Obesity: should treatment target visceral afferents? Physiol Behav 2005;86:698–708.CrossRef Powel TL, Chi MM, Schier LA, et al. Obesity: should treatment target visceral afferents? Physiol Behav 2005;86:698–708.CrossRef
29.
go back to reference McMahon MJ, Johnston D, Hill GL, et al. Treatment of severe side effects after vagotomy and gastroenterostomy by closure of gastroenterostomy without pyloroplasty. Br Med J 1979;1:7–8.CrossRef McMahon MJ, Johnston D, Hill GL, et al. Treatment of severe side effects after vagotomy and gastroenterostomy by closure of gastroenterostomy without pyloroplasty. Br Med J 1979;1:7–8.CrossRef
30.
go back to reference Clements RH, Gonzalez QH, Long CI, et al. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 2004;70(1):1–4. Jan.PubMed Clements RH, Gonzalez QH, Long CI, et al. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 2004;70(1):1–4. Jan.PubMed
31.
go back to reference Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004;240(2):236–42. Aug.CrossRef Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004;240(2):236–42. Aug.CrossRef
32.
go back to reference Borg CM, le Roux CW, Ghatei MA, et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006;93(2):210–5. Feb.CrossRef Borg CM, le Roux CW, Ghatei MA, et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006;93(2):210–5. Feb.CrossRef
33.
go back to reference Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008;247(3):401–7. Mar.CrossRef Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008;247(3):401–7. Mar.CrossRef
34.
go back to reference le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246(5):780–5. Nov.CrossRef le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246(5):780–5. Nov.CrossRef
35.
go back to reference Sundbom M, Holdstock C, Engström BE, et al. Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 2007;17(3):304–10. Mar.CrossRef Sundbom M, Holdstock C, Engström BE, et al. Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 2007;17(3):304–10. Mar.CrossRef
Metadata
Title
Vagal Nerve Dissection During Pouch Formation in Laparoscopic Roux-Y-Gastric Bypass for Technical Simplification: Does it Matter?
Authors
A. Perathoner
H. Weiss
W. Santner
G. Brandacher
E. Laimer
E. Höller
F. Aigner
A. Klaus
Publication date
01-04-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 4/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9657-x

Other articles of this Issue 4/2009

Obesity Surgery 4/2009 Go to the issue